RecruitingPhase 1NCT06578000

Efficacy of Iontophoresis in Treating Lateral Epicondylitis Patients

Efficacy of Iontophoresis in Treating Lateral Epicondylitis Patients a Randomised Controlled Trial


Sponsor

NOUR ALI ABO EL ELAA FRAGHLY

Enrollment

40 participants

Start Date

Sep 1, 2024

Study Type

INTERVENTIONAL

Summary

This study is conducted To evaluate the effect of magnesium sulfate on pain intensity, muscle power, hand grip and function ability in patients with lateral epicondylitis.


Eligibility

Min Age: 20 YearsMax Age: 50 Years

Inclusion Criteria4

  • Their age will be ranged between 20-50 years with both gender
  • Pain on the lateral side of the elbow for at least 4 weeks
  • Tenderness over the lateral epicondyle
  • At least two positive provocative tests: Mill test and Thomson test

Exclusion Criteria12

  • History of injection, surgery, physical therapy in the elbow area in the last 3 months
  • Previous elbow surgery
  • History of radius/ulna fracture
  • History of cervical and shoulder problems
  • Having bilateral symptoms
  • Concomitant medial epicondylitis
  • Malignancy
  • Pregnancy
  • Systemic rheumatologic disease or systemic infection
  • Inserted cardiac pacemaker
  • Presence of coagulation disorders
  • Cognitive dysfunction

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMagnesium sulfate

Iontophoresis therapy (MgO4 will be applied to the active positive electrode and the treatment will be repeated twice a week for four weeks) + conventional therapy (Splint + Stretch + strength).

OTHERconventional therapy

conventional therapy (Splint + Stretch + strength) twice a week for six weeks


Locations(1)

Faculty of Physical Therapy

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06578000